These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3321877)

  • 1. Timolol/pilocarpine combination eye drops in open angle glaucoma and in ocular hypertension. A controlled randomized study.
    Høvding G; Aasved H
    Acta Ophthalmol (Copenh); 1987 Oct; 65(5):594-601. PubMed ID: 3321877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twelve-hour IOP control obtained by a single dose of timolol/pilocarpine combination eye drops.
    Løfors KT; Høvding G; Viksmoen L; Aasved H; Bergaust B; Bulie T
    Acta Ophthalmol (Copenh); 1990 Jun; 68(3):323-6. PubMed ID: 2203218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined timolol and pilocarpine vs pilocarpine alone and timolol alone in the treatment of glaucoma.
    Zadok D; Geyer O; Zadok J; Lazar M; Krakowski D; Nemet P
    Am J Ophthalmol; 1994 Jun; 117(6):728-31. PubMed ID: 8198156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timolol-pilocarpine combined vs timolol and pilocarpine given separately.
    Söderström MB; Wallin O; Granström PA; Thorburn W
    Am J Ophthalmol; 1989 May; 107(5):465-70. PubMed ID: 2653044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group.
    Strahlman ER; Vogel R; Tipping R; Clineschmidt CM
    Ophthalmology; 1996 Aug; 103(8):1283-93. PubMed ID: 8764800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two fixed beta-blocker-pilocarpine combinations. The Carteolol-Pilocarpine Study Group.
    Bron AM; Garcher CP; Sirbat D; Allaire CM; Lablache-Combier MJ; Trinquand CJ
    Eur J Ophthalmol; 1997; 7(4):351-6. PubMed ID: 9457458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Michaud JE; Friren B;
    Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular tension and pupil diameter effects of timolol 0.50% and pilocarpine 2% or 4% in association.
    Taverniti L; Voccia L; Amoroso L; De Stefano C; Virno M
    Acta Ophthalmol Scand Suppl; 1997; (224):55-6. PubMed ID: 9589741
    [No Abstract]   [Full Text] [Related]  

  • 9. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.
    Adamsons IA; Polis A; Ostrov CS; Boyle JE
    J Glaucoma; 1998 Dec; 7(6):395-401. PubMed ID: 9871861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group.
    Boyle JE; Ghosh K; Gieser DK; Adamsons IA
    Ophthalmology; 1998 Oct; 105(10):1945-51. PubMed ID: 9787368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levobunolol vs timolol for open-angle glaucoma and ocular hypertension.
    Cinotti A; Cinotti D; Grant W; Jacobs I; Galin M; Silverstone D; Shin D; Esters J; Lee J; Bouchey R
    Am J Ophthalmol; 1985 Jan; 99(1):11-7. PubMed ID: 3881032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical brimonidine 0.2%/timolol 0.5% ophthalmic solution: in glaucoma and ocular hypertension.
    Frampton JE
    Drugs Aging; 2006; 23(9):753-61. PubMed ID: 17020399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension].
    Sirbat D; Charlin JF; Cohn H; Dascotte JC; George JL; Lesure P; Massin M; Massin G; Maurin JF; Renard JP
    J Fr Ophtalmol; 1995; 18(10):589-96. PubMed ID: 8568162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral and topical adrenergic beta-receptor blockers in glaucoma treatment. A multicenter study.
    Ohrström A; Kättström O; Polland W; Mortensen J; Stenström B
    Acta Ophthalmol (Copenh); 1984 Oct; 62(5):681-95. PubMed ID: 6391072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
    Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term effect of apraclonidine on intraocular pressure in glaucoma patients receiving timolol and pilocarpine.
    Yüksel N; Elibol O; Caglar Y; Alçelik T
    Ophthalmologica; 1997; 211(6):354-7. PubMed ID: 9380353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tafluprost/Timolol: A Review in Open-Angle Glaucoma or Ocular Hypertension.
    Hoy SM
    Drugs; 2015 Oct; 75(15):1807-13. PubMed ID: 26431840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide.
    Boyle JE; Ghosh K; Gieser DK; Adamsons IA
    Ophthalmology; 1999 Dec; 106(12 Suppl):10-6. PubMed ID: 10598692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanoprost Study Group.
    Nordmann JP; Söderström M; Rouland JF; Malecaze F
    Br J Ophthalmol; 2000 Feb; 84(2):181-5. PubMed ID: 10655195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.